Technology that can identify stray bits of genetic material in the environment can help scientists monitor human and animal health.
Candidate: Tollovir™ (NLC-V-01) Type: 3CL protease inhibitor being developed through a joint venture between Todos Medical and NLC Pharma. 2021 Status: Todos Medical said April 19...
Credit: College of Engineering & Applied Science, University of Colorado Boulder When disease outbreaks happen, response time in developing and distributing treatments is crucial to saving...
Credit: © 2021 KAUST; Ivan Gromicho A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting...
Study at Tel Aviv University based on data from 300,000 tests for COVID-19 Credit: Tel Aviv University A new study at Tel Aviv University found that...
A moral philosopher explains why the ethics of getting or refusing the COVID-19 vaccine are more complex than it might seem.
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a Q&A session with the Alliance for a Stronger...
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a Q&A session with the Alliance for a Stronger...
Variants of the original SARS-CoV-2 are now in wide circulation. That means the third wave of COVID-19 has come with new questions about the variants, their...
Both the AstraZeneca and Johnson & Johnson vaccines are now being investigated for links to rare blood disorders.